Semin Respir Crit Care Med 2021; 42(03): 460-470
DOI: 10.1055/s-0041-1727250
Review Article

Mycobacteria: Selection of Transplant Candidates and Post–lung Transplant Outcomes

Daniel Z.P. Friedman
1  Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
2  Division of Infectious Disease, Department of Medicine, Mayo Clinic, Rochester, Minnesota
,
Karen Doucette
1  Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
› Author Affiliations

Abstract

Mycobacterium is a large, clinically relevant bacterial genus made up of the agents of tuberculosis and leprosy and hundreds of species of saprophytic nontuberculous mycobacteria (NTM). Pathogenicity, clinical presentation, epidemiology, and antimicrobial susceptibilities are exceptionally diverse between species. Patients with end-stage lung disease and recipients of lung transplants are at a higher risk of developing NTM colonization and disease and of severe manifestations and outcomes of tuberculosis. Data from the past three decades have increased our knowledge of these infections in lung transplant recipients. Still, there are knowledge gaps to be addressed to further our understanding of risk factors and optimal treatments for mycobacterial infections in this population.



Publication History

Publication Date:
24 May 2021 (online)

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA